Sovran Advisors, LLC CLDX Holdings History
Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-538,920.75
% of Total Estimate Gain
-17.53%
Sovran Advisors, LLC's Celldex Therapeutics Inc Holding Summary
As of 2025-03-31, Sovran Advisors, LLC held - shares of Celldex Therapeutics Inc(CLDX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Sovran Advisors, LLC now holds 0% of the outstanding Celldex Therapeutics Inc(CLDX) stock.
The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $22.34 for 113,457.00 shares. Based on historical transaction data and CLDX's current price of $22.00, Sovran Advisors, LLC's estimated gain on his CLDX holdings is $-538,920.75, reflecting a -17.53% gain to date.
Sovran Advisors, LLC CLDX ($22.00) Holding Chart
Sovran Advisors, LLC CLDX ($22.00) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1